| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964507 | Vaccine | 2015 | 7 Pages |
Abstract
Immunological responses and safety results support the use of PCV13 for catch-up schedules in older infants and children naïve to pneumococcal vaccination.
Keywords
GMCserious AEPCV13PCV7SAEIPDImmunizationImmunogenicityimmunoglobulin Invasive pneumococcal diseaseEnzyme-linked immunosorbent assayELISAadverse eventconfidence intervalGeometric mean concentration7-valent pneumococcal conjugate vaccinePneumococcal conjugate vaccine13-Valent pneumococcal conjugate vaccine
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jacek Wysocki, Jerzy Brzostek, Henryk SzymaÅski, BogusÅaw Tetiurka, Ewa Toporowska-Kowalska, Krystyna Wasowska-Królikowska, Denise A. Sarkozy, Peter C. Giardina, William C. Gruber, Emilio A. Emini, Daniel A. Scott,